Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis

NCT02183038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharyngitis

Interventions

DRUG: Meloxicam low
DRUG: Meloxicam high
DRUG: Naproxen sodium
DRUG: Meloxicam placebo low
DRUG: Meloxicam placebo high
DRUG: Naproxen sodium placebo

Sponsor

Boehringer Ingelheim